Literature DB >> 22160277

Declining rates of hepatocellular carcinoma in urban Shanghai: incidence trends in 1976-2005.

Shan Gao1, Wan-Shui Yang, Freddie Bray, Puthiery Va, Wei Zhang, Jing Gao, Yong-Bing Xiang.   

Abstract

In China, hepatocellular carcinoma (HCC) incidence rates in several registry catchment populations are amongst the highest worldwide. The incidence rates in urban Shanghai were analyzed between 1976 and 2005 to describe and interpret the time trends. Age-specific and age-standardized rates were calculated and graphically presented. An age-period-cohort model was fitted to assess the effects of age at diagnosis, calendar period, and birth cohort on the changing HCC incidence rates. In total, 35,241 and 13,931 men and women were diagnosed with HCC during 1976-2005 in urban Shanghai. The age-standardized incidence rates in urban Shanghai were 33.9 per 10(5) among men and 11.4 per 10(5) among women in 1976-1980, but decreased in both sexes to 25.8 per 10(5) and 8.5 per 10(5), respectively by 2001-2005. Accelerating rates in birth cohorts born in the early-1930s and decelerating rates circa 1945 were observed in both sexes, with further accelerations noted in the late-1950s (in women) and early-1960s (in men). Given the parameterization, increases in risk of HCC were seen in successive male and female generations between 1900 and 1935, followed by a further increase among successive cohorts born around 1960, with a reduction in risk in the most recent generations. The incidence rates of HCC in urban Shanghai from 1976 to 2005 have declined in both sexes, with the complex but similar patterns observed in successive generations suggestive of a shared changing prevalence in risk factors in men and women, with a role possibly for HBV interventions reducing risk of HCC in cohorts born after 1960.

Entities:  

Mesh:

Year:  2011        PMID: 22160277      PMCID: PMC5477645          DOI: 10.1007/s10654-011-9636-8

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  24 in total

1.  Age-period-cohort models for the Lexis diagram.

Authors:  B Carstensen
Journal:  Stat Med       Date:  2007-07-10       Impact factor: 2.373

2.  Prevention of hepatitis B in China: achievements and challenges.

Authors:  Feng-Min Lu; Hui Zhuang
Journal:  Chin Med J (Engl)       Date:  2009-12-20       Impact factor: 2.628

3.  Models for temporal variation in cancer rates. II: Age-period-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

Review 4.  Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China.

Authors:  G B Yao
Journal:  Gut       Date:  1996       Impact factor: 23.059

5.  A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.

Authors:  S Zhao; Z Xu; Y Lu
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

6.  Incidence of primary liver cancer in Italy between 1988 and 2002: an age-period-cohort analysis.

Authors:  Luigino Dal Maso; Mauro Lise; Paola Zambon; Emanuele Crocetti; Diego Serraino; Fulvio Ricceri; Marina Vercelli; Vincenzo De Lisi; Giovanna Tagliabue; Massimo Federico; Fabio Falcini; Tiziana Cassetti; Andrea Donato; Mario Fusco; Mario Budroni; Stefano Ferretti; Rosario Tumino; Silvano Piffer; Francesco Bellù; Lucia Mangone; Adriano Giacomin; Susanna Vitarelli; Silvia Franceschi
Journal:  Eur J Cancer       Date:  2007-12-26       Impact factor: 9.162

7.  Age-period-cohort modelling of non-Hodgkin's lymphoma incidence in a French region: a period effect compatible with an environmental exposure.

Authors:  Jean-François Viel; Evelyne Fournier; Arlette Danzon
Journal:  Environ Health       Date:  2010-08-08       Impact factor: 5.984

Review 8.  Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection.

Authors:  Shu-Chun Chuang; Carlo La Vecchia; Paolo Boffetta
Journal:  Cancer Lett       Date:  2008-12-16       Impact factor: 8.679

9.  Age-period-cohort analysis of hepatocellular carcinoma mortality in Taiwan, 1976-2005.

Authors:  Long-Teng Lee; Hsiao-Yuan Huang; Kuo-Chin Huang; Ching-Yu Chen; Wen-Chung Lee
Journal:  Ann Epidemiol       Date:  2009-05       Impact factor: 3.797

10.  Chronic viral hepatitis and hepatocellular carcinoma.

Authors:  Yagil Barazani; Jonathan R Hiatt; Myron J Tong; Ronald W Busuttil
Journal:  World J Surg       Date:  2007-06       Impact factor: 3.282

View more
  39 in total

1.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

2.  International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007.

Authors:  Jessica L Petrick; Megan Braunlin; Mathieu Laversanne; Patricia C Valery; Freddie Bray; Katherine A McGlynn
Journal:  Int J Cancer       Date:  2016-06-28       Impact factor: 7.396

Review 3.  Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability.

Authors:  Katherine A McGlynn; Jessica L Petrick; W Thomas London
Journal:  Clin Liver Dis       Date:  2015-02-26       Impact factor: 6.126

4.  Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women.

Authors:  W S Yang; X O Shu; J Gao; H L Li; H Cai; G Yang; B T Ji; N Rothman; Y T Gao; W Zheng; Y B Xiang
Journal:  Ann Oncol       Date:  2013-02-13       Impact factor: 32.976

5.  Prospective cohort studies of association between family history of liver cancer and risk of liver cancer.

Authors:  Yang Yang; Qi-Jun Wu; Li Xie; Wong-Ho Chow; Nat Rothman; Hong-Lan Li; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Yong-Bing Xiang
Journal:  Int J Cancer       Date:  2014-03-07       Impact factor: 7.396

6.  Incidence trends of urinary bladder and kidney cancers in urban Shanghai, 1973-2005.

Authors:  Yang Yang; Li Xie; Jia-Li Zheng; Yu-Ting Tan; Wei Zhang; Yong-Bing Xiang
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

7.  Combination of human leukocyte antigen and killer cell immunoglobulin-like receptor genetic background influences the onset age of hepatocellular carcinoma in male patients with hepatitis B virus infection.

Authors:  Ning Pan; Jie Qiu; Hang Sun; Fengqin Miao; Qian Shi; Jinhuan Xu; Wei Jiang; Hui Jin; Wei Xie; Youji He; Jianqiong Zhang
Journal:  Clin Dev Immunol       Date:  2013-11-10

8.  International trends in primary liver cancer incidence from 1973 to 2007.

Authors:  Yue Zhang; Jian-Song Ren; Ju-Fang Shi; Ni Li; Yu-Ting Wang; Chunfeng Qu; Yawei Zhang; Min Dai
Journal:  BMC Cancer       Date:  2015-03-04       Impact factor: 4.430

9.  Time trend analysis of primary liver cancer incidence in Sihui county of Guangdong Province, China (1987-2011).

Authors:  Wenyi Liu; Qing Liu; Qihong Huang; Yuqiang Lu; Shanghang Xie; Aihua Lin; Sumei Cao
Journal:  BMC Cancer       Date:  2016-10-12       Impact factor: 4.430

10.  Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005.

Authors:  Qi-Jun Wu; Emily Vogtmann; Wei Zhang; Li Xie; Wan-Shui Yang; Yu-Ting Tan; Jing Gao; Yong-Bing Xiang
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.